<code id='FDFBC849AE'></code><style id='FDFBC849AE'></style>
    • <acronym id='FDFBC849AE'></acronym>
      <center id='FDFBC849AE'><center id='FDFBC849AE'><tfoot id='FDFBC849AE'></tfoot></center><abbr id='FDFBC849AE'><dir id='FDFBC849AE'><tfoot id='FDFBC849AE'></tfoot><noframes id='FDFBC849AE'>

    • <optgroup id='FDFBC849AE'><strike id='FDFBC849AE'><sup id='FDFBC849AE'></sup></strike><code id='FDFBC849AE'></code></optgroup>
        1. <b id='FDFBC849AE'><label id='FDFBC849AE'><select id='FDFBC849AE'><dt id='FDFBC849AE'><span id='FDFBC849AE'></span></dt></select></label></b><u id='FDFBC849AE'></u>
          <i id='FDFBC849AE'><strike id='FDFBC849AE'><tt id='FDFBC849AE'><pre id='FDFBC849AE'></pre></tt></strike></i>

          fashion

          fashion

          author:fashion    Page View:7
          Walmart seems poised to increase its health care footprint by buying value-based senior care company ChenMed. Joe Raedle/Getty Images

          Walmart seems poised to increase its health care footprint by buying value-based senior care company ChenMed, per reports from Bloomberg.

          Experts largely hailed the rumored sale as a good buy, citing the management of chronic conditions in the Medicare Advantage population through primary care, ChenMed’s specialty, as an area with huge innovation and cost savings over the last 10 years.

          advertisement

          “If you’re going to purchase primary care in the senior space, there’s no one better than ChenMed. The only other one that might be better or equivalent would be Oak Street, but they were just purchased,” said Jon Kaplan, a senior partner at BCG. “In the world of great primary care practices to buy, in my top two are Oak Street and ChenMed, and one of them’s available, one’s not.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more
          Amylyx ALS drug fails large clinical trial
          Amylyx ALS drug fails large clinical trial

          JustinKlee(left)andJoshuaCohenaretheco-foundersandco-CEOsofAmylyxPharmaceuticals.KayanaSzymczakforST

          read more
          How one medical school became remarkably diverse
          How one medical school became remarkably diverse

          ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

          read more

          Late stage cancers on the rise after pandemic delayed screenings

          Ahistologicalslideofcancerousbreasttissue.NationalCancerInstitute/NIHEarly-stagecancerdiagnosesdecre